ORACLE (R/R)

ORACLE (R/R)

Randomized Phase 3 Study Evaluating the Efficacy and the Safety of Oral Azacitidine (CC-486) Compared to Investigator's Choice Therapy in Patient With Relapsed or Refractory Angioimmunoblastic T Cell Lymphoma (ORACLE)


Study Treatments


Inclusion criteria


Exclusion criteria


Participating sites

Link